The World Health Organisation is developing a supranational vaccine authorisation mechanism – the Emergency Use Listing – which allows it to influence regulatory decisions inside sovereign states.

The mechanism aims to override national authorising bodies’ safety measures while absolving WHO and its funders of any legal responsibility.

In the following, Yaffa Shir-Raz and David Shuldman explain how WHO implemented this mechanism in Israel in 2020 using a Bill Gates polio vaccine, which, during the twists and turns of the global plot, required the help of the UK’s Medicines and Healthcare products Regulatory Agency to implement the scheme.

TRUTH LIVES on athttps://sgtreport.tv/

“Israel was the first Western arena in which the EUL mechanism was put into practice. This is not merely a local event. It serves as a test case for a new model – a practical examination of the WHO’s ability to shape approval processes in a Western country without bearing direct regulatory responsibility,” the authors write.

“Beyond the damage to sovereignty, the danger in this [EUL] model is deeper. [Unlike a national regulatory system,] the WHO does not bear legal responsibility within states and is not subject to judicial or parliamentary oversight there.”

ByYaffa Shir-RazandDavid Shuldman, as published byBrownstone Instituteon 23 April 2026

“I need to ask someone else to take responsibility for the second part of the approvals process, so that I won’t have a conflict of interest. I’m also working with Bill Gates and the World Health Organisation on the vaccine itself.”

This admission of a conflict of interest was made by Prof. Lester Schulman, secretary of the Ministry of Health’s polio committee, in March 2023, during an internal discussion about approving the importation into Israel of a new polio vaccine. The vaccine was developed and promoted by the World Health Organisation (“WHO”) in collaboration with the Bill & Melinda Gates Foundation, and its approval pathway relied on a new emergency authorisation mechanism the WHO has developed in recent years: the Emergency Use Listing (“EUL”).Although the remark was framed as a technical aside, it was an unusual confession of a conflict of interest by the committee’s secretary. Its seriousness is compounded by the fact that it was made only after the committee had already voted by an overwhelming majority to initiate the process of bringing the vaccine to Israel, and after it had already worked vigorously to persuade the Pharmaceutical Division to cooperate.

The quotation does not appear in the official minutes of the meeting that were provided to us. It is heard on an audio recording of the session, one of several recordings passed on to us by a whistle-blower. The minutes were provided only following a Freedom of Information request and subsequent litigation.

Source: SGT Report